达瑞生物 (832705.OC)

+ 收藏

财务摘要(报告期)(达瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.01-0.30-0.060.070.06
 每股收益 - 稀释(元) 0.01-0.30-0.060.070.06
 每股收益 - 期末股本摊薄(元) 0.01-0.30-0.060.070.06
 每股净资产BPS(元) 2.202.192.482.532.50
 每股经营活动产生的现金流量净额(元) 0.070.19-0.080.04-0.02
 每股营业收入(元) 0.370.720.371.630.74
关键比率:
 净资产收益率 - 摊薄(%) 0.52-13.81-2.232.922.32
 净资产收益率 - 加权(%) --12.92-2.212.942.27
 净资产收益率 - 平均(%) 0.52-12.81-2.212.922.30
 净资产收益率 - 扣除(%) --13.12-2.492.271.67
 总资产净利率 - 平均(%) 0.43-10.49-1.822.341.91
 总资产报酬率ROA(%) 0.13-8.55-2.511.911.96
 投入资本回报率ROIC(%) 0.10-13.26-2.332.501.98
 销售毛利率(%) 43.7044.3842.1540.6339.38
 销售净利率(%) 3.06-42.31-15.134.467.74
 资产负债率(%) 18.2615.8715.7020.5715.67
 资产周转率(倍) 0.140.250.120.520.25
 销售商品提供劳务收到的现金/营业收入(%) 90.15149.80131.4180.0492.06
 营业利润同比增长率(%) 121.28-428.56-202.87171.9369.70
 营业收入同比增长率(%) 1.40-55.90-50.3422.1618.45
 利润总额同比增长率(%) 117.24-449.68-212.96171.1570.09
 归属母公司股东的净利润同比增长率(%) 120.83-509.22-195.41236.1848.49
 扣非后归属母公司股东的净利润同比增长率(%) --599.76-247.7930.2249.43
 总资产同比增长率(%) -8.29-18.30-1.085.4326.33
 总负债同比增长率(%) 6.69-36.96-0.9132.88-12.98
 净资产同比增长率(%) -11.04-13.41-1.070.1338.01
利润表摘要:
 营业总收入(元) 103,957,692.49200,282,184.30102,524,247.63454,184,906.06206,440,662.82
 营业总成本(元) 101,009,328.11226,445,397.41119,852,478.38414,512,882.57190,351,645.84
 营业收入(元) 103,957,692.49200,282,184.30102,524,247.63454,184,906.06206,440,662.82
 营业利润(元) 3,977,690.34-62,183,237.89-18,695,852.5718,925,894.8818,174,231.88
 利润总额(元) 3,527,797.59-65,505,228.29-20,457,001.9918,732,668.6118,110,362.82
 净利润(元) 3,176,667.45-84,737,772.15-15,511,919.5020,269,395.4515,980,998.72
 归属母公司股东的净利润(元) 3,217,299.01-84,497,451.88-15,445,779.0920,648,194.1116,188,321.56
 非经常性损益(元) --4,195,511.791,773,637.024,580,074.854,537,040.14
 归属母公司股东的净利润扣除非经常性损益(元) --80,301,940.09-17,219,416.1116,068,119.2611,651,281.42
资产负债表摘要:
 流动资产(元) 394,217,617.32361,102,282.24490,988,026.67558,706,820.50497,794,675.82
 固定资产(元) 86,103,619.8890,997,778.7696,664,932.9097,448,227.4199,154,714.89
 长期股权投资(元) 2,142,442.922,032,832.805,561,295.719,963,647.0710,323,834.39
 资产总计(元) 751,492,502.75726,275,710.15819,463,123.44888,900,929.15828,382,602.88
 流动负债(元) 106,922,852.75105,702,490.81117,911,996.37174,631,269.11124,639,459.54
 非流动负债(元) 30,335,387.089,583,852.1110,740,285.148,257,482.975,199,718.47
 负债合计(元) 137,258,239.83115,286,342.92128,652,281.51182,888,752.08129,839,178.01
 股东权益(元) 614,234,262.92610,989,367.23690,810,841.93706,012,177.07698,543,424.87
 归属母公司股东的权益(元) 615,288,141.73612,002,614.47691,647,311.58706,782,506.31699,131,254.34
 资本公积(元) 336,007,658.08336,007,658.08346,428,710.05346,428,710.05343,653,080.37
 盈余公积(元) 15,667,605.0215,667,605.0215,667,605.0215,667,605.0215,667,605.02
 未分配利润(元) -16,105,513.17-19,322,812.1849,728,860.6165,174,639.7060,714,767.15
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 93,714,298.18300,021,356.13134,731,206.71363,510,739.19190,051,672.82
 经营活动产生的现金净流量(元) 18,467,666.3653,465,017.18-22,201,791.6211,490,651.95-5,904,162.60
 购建固定无形长期资产支付的现金(元) 4,692,959.6824,491,528.459,606,686.3839,534,159.6715,848,100.94
 投资支付的现金(元) 110,000,000.00480,000,000.00315,000,000.00496,000,000.00191,000,000.00
 投资活动产生的现金净流量(元) -12,916,294.08-168,764,974.97-59,188,338.71-26,807,143.05-94,645,474.69
 筹资活动产生的现金净流量(元) --3,074,078.68--50,875,070.55-48,463,532.60
 现金及现金等价物净增加(元) 5,608,645.80-118,256,841.87-81,064,966.93-65,293,307.09-148,561,342.63
 期末现金及现金等价物余额(元) 163,948,920.39158,340,274.59195,541,549.53276,597,116.46193,329,080.92
 折旧与摊销(元) 15,908,056.3435,264,357.6316,440,401.9532,711,042.7216,210,740.72
公告日期 2024-08-302024-03-292023-08-302023-03-302022-08-29
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院